Chelsea Counsel CO Pfizer Inc Transaction History

Chelsea Counsel CO

$200 Million
Q3 2024

A detailed history of Chelsea Counsel CO transactions in Pfizer Inc stock. As of the latest transaction made, Chelsea Counsel CO holds 25,870 shares of PFE stock, worth $681,933. This represents 0.37% of its overall portfolio holdings.

Number of Shares

25,870

Previous 26,170 1.15%

Holding current value

$681,933

Previous $732,000 2.19%

% of portfolio

0.37%

Previous 0.37%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 21, 2024	SELL	$27.7 - $31.39 $8,310 - $9,417	-300 Reduced 1.15%	25,870 $748,000
Q2 2024 Nov 21, 2024	SELL	$25.26 - $29.6 $41,173 - $48,248	-1,630 Reduced 5.86%	26,170 $732,000
Q1 2024 Jun 14, 2024	SELL	$25.89 - $29.73 $2,071 - $2,378	-80 Reduced 0.29%	27,800 $771,000
Q4 2023 Feb 21, 2024	SELL	$26.13 - $33.94 $109,615 - $142,378	-4,195 Reduced 13.08%	27,880 $802,000
Q3 2023 Nov 22, 2023	SELL	$32.09 - $37.51 $170,077 - $198,803	-5,300 Reduced 14.18%	32,075 $1.06 Million
Q2 2023 Nov 22, 2023	SELL	$36.12 - $41.79 $187,824 - $217,308	-5,200 Reduced 12.21%	37,375 $1.37 Million
Q1 2023 May 19, 2023	SELL	$39.39 - $51.28 $51,207 - $66,664	-1,300 Reduced 2.96%	42,575 $1.74 Million
Q4 2022 Feb 23, 2023	SELL	$41.75 - $54.5 $148,630 - $194,020	-3,560 Reduced 7.51%	43,875 $2.25 Million
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $672,459 - $820,905	-15,367 Reduced 24.47%	47,435 $2.08 Million
Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $455,389 - $539,948	-9,787 Reduced 13.48%	62,802 $3.29 Million
Q1 2022 May 24, 2022	SELL	$45.75 - $56.69 $1.18 Million - $1.46 Million	-25,807 Reduced 26.23%	72,589 $3.76 Million
Q4 2021 May 23, 2022	SELL	$41.32 - $61.25 $474,353 - $703,150	-11,480 Reduced 10.45%	98,396 $5.81 Million
Q3 2021 Feb 10, 2022	BUY	$39.25 - $50.42 $89,293 - $114,705	2,275 Added 2.11%	109,876 $4.73 Million
Q2 2021 Feb 10, 2022	BUY	$35.91 - $40.68 $79,720 - $90,309	2,220 Added 2.11%	107,601 $4.21 Million
Q1 2021 Feb 10, 2022	BUY	$33.49 - $37.77 $15,907 - $17,940	475 Added 0.45%	105,381 $3.82 Million
Q4 2020 Mar 08, 2022	BUY	$33.47 - $42.56 $1.79 Million - $2.27 Million	53,444 Added 103.85%	104,906 $3.86 Million
Q3 2020 May 06, 2022	BUY	$31.75 - $37.25 $698 - $819	22 Added 0.04%	51,462 $1.89 Million
Q2 2020 May 06, 2022	BUY	$30.12 - $36.54 $259,664 - $315,011	8,621 Added 20.13%	51,440 $1.68 Million
Q1 2020 Jun 12, 2020	SELL	$27.03 - $38.62 $13,515 - $19,310	-500 Reduced 1.15%	42,819 $1.4 Million
Q4 2019 Mar 23, 2020	SELL	$32.92 - $37.36 $3,292 - $3,736	-100 Reduced 0.23%	43,319 $1.7 Million
Q3 2019 Mar 23, 2020	SELL	$32.49 - $42.13 $16,245 - $21,065	-500 Reduced 1.14%	43,419 $0
Q2 2019 Dec 09, 2019	SELL	$36.98 - $41.52 $702 - $788	-19 Reduced 0.04%	43,919 $1.9 Million
Q1 2019 Dec 09, 2019	SELL	$37.5 - $41.2 $5,625 - $6,180	-150 Reduced 0.34%	43,938 $1.87 Million
Q2 2018 Oct 03, 2018	BUY	$32.98 - $35.16 $1.27 Million - $1.35 Million	38,446 Added 681.43%	44,088 $1.6 Million
Q4 2017 Jan 12, 2018	SELL	$33.26 - $35.29 $83,150 - $88,225	-2,500 Reduced 30.7%	5,642 $204,000
Q2 2017 Jan 22, 2018	BUY	N/A	8,142	8,142 $273,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

News

Stay updated on Chelsea Counsel CO with notifications on news.

Account

Chelsea Counsel CO Pfizer Inc Transaction History